Medley

Medley Net Margin

The Net Profit Margin of Medley (4480.T) as of Oct 9, 2026 is 2.65 %. In the previous year, Net Profit Margin was 9.55 % — a change of -72.24% (lower).

Net Margin

2.65 %

YoY

-72.24%

Last updated:

Net Profit Margin of Medley is 2025 2.65 % . Net Profit Margin of Medley was 2024 9.55 % . It decreases by -72.24% lower compared to the previous year.

Medley's net margin stands at 2.7%, down from 5.2% several years earlier.

The Medley Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-5.24 JPY
Jan 1, 2019
-8.00 JPY
Jan 1, 2020
6.68 JPY
Jan 1, 2021
5.18 JPY
Jan 1, 2022
7.17 JPY
Jan 1, 2023
12.50 JPY
Jan 1, 2024
9.55 JPY
Jan 1, 2025
2.65 JPY
The Medley Net Margin history
YEARNet MarginYoY
2.65 %-72.24%
9.55 %-23.59%
12.50 %+74.31%
7.17 %+38.34%
5.18 %-22.37%
6.68 %-183.44%
-8.00 %+52.80%
-5.24 %-351.49%
2.08 %—
Access this data via the Eulerpool API

Medley Stock analysis

What does Medley do? Medley Inc is a global company specializing in the production and sale of pharmaceutical products. The company was founded in 1985 as a small business and has since become a leading player in the pharmaceutical industry, operating in over 150 countries. Medley Inc produces a variety of products in different areas such as cardiology, gastroenterology, oncology, orthopedics, neurology, and dermatology. The company's business model is based on the development and sale of generic products, which are imitation products of patented drugs. Medley Inc focuses on producing high-quality and effective medicines at competitive prices. The company has production sites in various countries to meet the demand for drugs in each region. In addition to being a manufacturer of medicines, Medley Inc also offers services such as drug distribution, clinical studies, research and development, consulting for pharmaceutical manufacturers, and customer training. The company places great importance on the quality and safety of its products and services and has implemented a comprehensive quality management system to meet its high standards. The product range of Medley Inc includes a variety of drugs used in different indications, including well-known drugs such as Tamoxifen for cancer, Fluoxetine for depression, Oxycodone for pain relief, and Levofloxacin as an antibiotic. Medley Inc strives to make affordable medications accessible to all people and works to improve healthcare worldwide. The company has formed long-term partnerships with organizations and governments in emerging countries to enhance access to affordable medicines. Overall, Medley Inc is a significant player in the pharmaceutical industry, focusing on the production of generics and improving healthcare globally. Through its efforts in quality, innovation, and partnerships, the company aims to have a positive impact on society. Medley is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medley stock

Net Profit Margin of Medley is 2.65 % in 2025.

Net Profit Margin of Medley changed from 9.55 % to 2.65 %, representing a -72.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Medley since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Medley with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Medley

All Key Metrics — Medley